The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia

Por Papakonstantinou, Nikos, Ntoufa, Stavroula, Chartomatsidou, Elisavet, Kotta, Konstantia, Agathangelidis, Andreas, Giassafaki, Lefki, Karamanli, Tzeni, Bele, Panagiota, Moysiadis, Theodoros, Baliakas, Panagiotis, Sutton, Lesley Ann, Stavroyianni, Niki, Anagnostopoulos, Achilles, Makris, Antonios M., Ghia, Paolo, Rosenquist, Richard, Stamatopoulos, Kostas
Publicado no Oncotarget (2016)